Firetrail Investments stockpicker Eleanor Swanson on hunt for next success story

New Conference Manager Eleanor Swanson was instrumental in convincing the investment team at Firetrail Investments to buy into AfterPay.
Eleanor Swanson, a fund manager with Firetrail Investments, will be at the Sohn Hearts & Minds Conference in December. Picture: Jane Dempster

Glenda Korporaal

Firetrail Investments stockpicker Eleanor Swanson on hunt for next success story

November 15, 2021
New Conference Manager Eleanor Swanson was instrumental in convincing the investment team at Firetrail Investments to buy into AfterPay.
Read Transcript

Eleanor Swanson was having difficulty convincing the investment team to buy into Afterpay.

It was 2019, and Swanson, then 28, had just left Macquarie’s successful high conviction fund to set up a new shop – Firetrail Investments – with eight others.

And Afterpay, which had listed on the ASX just a year earlier, was far from the buy-now, pay later giant which would eventually be sold to American payments firm Square in a $39bn deal.

“It was the classic millennial thing … My friends were using it, we are more accustomed to shopping online,” Swanson says. “I said it was a fantastic company. I had experienced it first hand and was using it for shopping.

“But some of the older guys in the view took the view that it was a short-term bubble. They didn’t see it as having longevity.”

One colleague described the share price – $8 – as “crazy”.

After considerable discussion, Firetrail decided it was worth a closer look. In her internal pitch, Swanson argued Afterpay shares were worth at least $50.

“We looked at how the customer transacted on the platform,” she says. “The customer might use it twice in the first year, but by the time they have been on the platform for three years they are using it 20 times a year.

“The average value of the order was also increasing.

“When you put those two metrics together – the frequency of spend, and the average order, and assumed a growing penetration of the millennial market – we were getting an enormous upside.”

The pitch was convincing. Afterpay – and the investment along with it – become a major success.

Firetrail, with a small cap fund now worth some $300m, sold out when Afterpay’s share price rose above $90. Its hedge fund held on until it rose above $100.

Now Swanson will make her debut at Sohn Hearts & Minds in December – one of 16 stock pickers predicting the best equity plays for the year ahead.

An analyst at the small cap fund, Swanson’s remit stretches from healthcare to biotechs and industrial stocks. (Swanson, who has also worked as an analyst at JP Morgan, is the daughter of ClearView Wealth managing director Simon Swanson.)

For her Sohn conference pick – to be revealed on the day – she has chosen a small cap Australian company in the tech sector.

“It is playing into the global growth thematic,” she says.

“It is an Australian company which has built a product here and is now taking it offshore and building a global business.”

Firetrail’s small caps fund can take in companies with market capitalisations of more than $200m up to ASX 50 companies.

Swanson says the fund has a flexible approach to stock picking, looking for a combination of growth and value stocks.

“Our investment philosophy is that every company has a price,” she says. “We do have more of a bias to companies with earnings as we believe share prices follow earnings. But we are very happy to play in the growth part of the market … we see a company’s valuation as very important.

“We would never buy a company just because we liked the thematic or like the space.

“We always build a proper model and figure it out. We want to see if there is upside based on where we think the earnings will land relative to market expectations. One of our best stock picks has been where we have found an angle on a company the markets have not cottoned on to yet.”

Swanson cites Beacon Lighting as one of the fund’s successful small cap investments.

“Eighteen months ago, we cottoned on to the fact they were rolling out a trade strategy instead of just focusing on the retail market.

“It has been a great performer for the fund. Finding that angle gave us a great point of differentiation to model out the earnings.”

Swanson says a background in science has given her an insight into healthcare and biotech stocks. Her picks have included New Zealand wound care product company Aroa Biosurgery.

“It listed on the ASX about June last year and it was one of our top picks. We actually invested just before the IPO when it was hard for companies to get their hands on capital.

“We stepped up pre-IPO and then helped them underwrite the IPO a few months later. It has been a great performer for us.”

The fund’s favourite industrial stock at the moment is outdoor advertising company oOh!Media.

“We think the market is underestimating how strong the advertising market is going to be next year,” Swanson says.

“Australians have saved over $150bn during lockdowns, not being able to travel or go out to dinner and having benefited from stimulus payments.

“We think there is enormous pent-up demand and there are companies which will want to make sure they get their share of the pie.” She says oOh! Media has a big presence in airports, which she believes will benefit as Australians resume domestic travel.

“We think they are going to be flat to up on their revenue prior to Covid whereas the market is thinking they wont be able to get back to where they were in 2019.”

She also likes Ardent Leisure, the leisure and outdoor theme park company whose fortunes were hit by the tragedy at Dreamworld on the Gold Coast in 2016. Her analysis sees the company potentially generating earnings before interest and tax at $120m compared to its current $80m.

She believes its US leisure centres, which operate under the brand Main Event, are turning around and generating more revenue, becoming its main asset.

Swanson, whose short career in funds management has never seen a down market, says she has benefited from the rush of IPOs on the ASX in the past 18 months.

“It has been an incredibly hot market for IPOs,” she says.

“I have learned a huge amount in terms of how to do due diligence. You have to make sure you not only speak to the chief executive and the chief financial officer, but also talk to their customers and ex-employees to get a holistic view of a company.”

She says the fund takes a three-year view when it looks at whether to invest in an IPO.

“We are not going to jump into an IPO because we think it is going to go up 20 or 30 per cent on one day,” she says. “Our favourite company is one which is genuinely coming to the market because it has a huge growth opportunity and needs capital.

“It’s always a red flag if a company is coming to the market opportunistically for no reason, or driven by private equity or the founders wanting to get out.”

Swanson says she is more than happy concentrating on the small cap sector in Australia.

“There are so many fantastic companies acrossall parts of the market – outstanding resource companies, mining services, financial services.

“Our big cap team is excited if they find a company that has 30 per cent upside. But (at the small cap fund) we are excited to find a company which has 200 to 300 per cent upside. The opportunities are so much more elevated with small companies. We always have at least 20 stock ideas.”

The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

This year’s conference in Australia, online as a result of the Covid-19 pandemic, will feature a video appearance by Warren Buffett’s colleague, Charlie Munger. It will also hear from Caledonia Investments chairman Mark Nelson and Regal Funds chief investment officer Phil King.

The local conferences, which began in 2016 have raised more than $30m for medical research.

The Sohn Hearts & Minds Conference will be held on December 3.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Eleanor Swanson was having difficulty convincing the investment team to buy into Afterpay.

It was 2019, and Swanson, then 28, had just left Macquarie’s successful high conviction fund to set up a new shop – Firetrail Investments – with eight others.

And Afterpay, which had listed on the ASX just a year earlier, was far from the buy-now, pay later giant which would eventually be sold to American payments firm Square in a $39bn deal.

“It was the classic millennial thing … My friends were using it, we are more accustomed to shopping online,” Swanson says. “I said it was a fantastic company. I had experienced it first hand and was using it for shopping.

“But some of the older guys in the view took the view that it was a short-term bubble. They didn’t see it as having longevity.”

One colleague described the share price – $8 – as “crazy”.

After considerable discussion, Firetrail decided it was worth a closer look. In her internal pitch, Swanson argued Afterpay shares were worth at least $50.

“We looked at how the customer transacted on the platform,” she says. “The customer might use it twice in the first year, but by the time they have been on the platform for three years they are using it 20 times a year.

“The average value of the order was also increasing.

“When you put those two metrics together – the frequency of spend, and the average order, and assumed a growing penetration of the millennial market – we were getting an enormous upside.”

The pitch was convincing. Afterpay – and the investment along with it – become a major success.

Firetrail, with a small cap fund now worth some $300m, sold out when Afterpay’s share price rose above $90. Its hedge fund held on until it rose above $100.

Now Swanson will make her debut at Sohn Hearts & Minds in December – one of 16 stock pickers predicting the best equity plays for the year ahead.

An analyst at the small cap fund, Swanson’s remit stretches from healthcare to biotechs and industrial stocks. (Swanson, who has also worked as an analyst at JP Morgan, is the daughter of ClearView Wealth managing director Simon Swanson.)

For her Sohn conference pick – to be revealed on the day – she has chosen a small cap Australian company in the tech sector.

“It is playing into the global growth thematic,” she says.

“It is an Australian company which has built a product here and is now taking it offshore and building a global business.”

Firetrail’s small caps fund can take in companies with market capitalisations of more than $200m up to ASX 50 companies.

Swanson says the fund has a flexible approach to stock picking, looking for a combination of growth and value stocks.

“Our investment philosophy is that every company has a price,” she says. “We do have more of a bias to companies with earnings as we believe share prices follow earnings. But we are very happy to play in the growth part of the market … we see a company’s valuation as very important.

“We would never buy a company just because we liked the thematic or like the space.

“We always build a proper model and figure it out. We want to see if there is upside based on where we think the earnings will land relative to market expectations. One of our best stock picks has been where we have found an angle on a company the markets have not cottoned on to yet.”

Swanson cites Beacon Lighting as one of the fund’s successful small cap investments.

“Eighteen months ago, we cottoned on to the fact they were rolling out a trade strategy instead of just focusing on the retail market.

“It has been a great performer for the fund. Finding that angle gave us a great point of differentiation to model out the earnings.”

Swanson says a background in science has given her an insight into healthcare and biotech stocks. Her picks have included New Zealand wound care product company Aroa Biosurgery.

“It listed on the ASX about June last year and it was one of our top picks. We actually invested just before the IPO when it was hard for companies to get their hands on capital.

“We stepped up pre-IPO and then helped them underwrite the IPO a few months later. It has been a great performer for us.”

The fund’s favourite industrial stock at the moment is outdoor advertising company oOh!Media.

“We think the market is underestimating how strong the advertising market is going to be next year,” Swanson says.

“Australians have saved over $150bn during lockdowns, not being able to travel or go out to dinner and having benefited from stimulus payments.

“We think there is enormous pent-up demand and there are companies which will want to make sure they get their share of the pie.” She says oOh! Media has a big presence in airports, which she believes will benefit as Australians resume domestic travel.

“We think they are going to be flat to up on their revenue prior to Covid whereas the market is thinking they wont be able to get back to where they were in 2019.”

She also likes Ardent Leisure, the leisure and outdoor theme park company whose fortunes were hit by the tragedy at Dreamworld on the Gold Coast in 2016. Her analysis sees the company potentially generating earnings before interest and tax at $120m compared to its current $80m.

She believes its US leisure centres, which operate under the brand Main Event, are turning around and generating more revenue, becoming its main asset.

Swanson, whose short career in funds management has never seen a down market, says she has benefited from the rush of IPOs on the ASX in the past 18 months.

“It has been an incredibly hot market for IPOs,” she says.

“I have learned a huge amount in terms of how to do due diligence. You have to make sure you not only speak to the chief executive and the chief financial officer, but also talk to their customers and ex-employees to get a holistic view of a company.”

She says the fund takes a three-year view when it looks at whether to invest in an IPO.

“We are not going to jump into an IPO because we think it is going to go up 20 or 30 per cent on one day,” she says. “Our favourite company is one which is genuinely coming to the market because it has a huge growth opportunity and needs capital.

“It’s always a red flag if a company is coming to the market opportunistically for no reason, or driven by private equity or the founders wanting to get out.”

Swanson says she is more than happy concentrating on the small cap sector in Australia.

“There are so many fantastic companies acrossall parts of the market – outstanding resource companies, mining services, financial services.

“Our big cap team is excited if they find a company that has 30 per cent upside. But (at the small cap fund) we are excited to find a company which has 200 to 300 per cent upside. The opportunities are so much more elevated with small companies. We always have at least 20 stock ideas.”

The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

This year’s conference in Australia, online as a result of the Covid-19 pandemic, will feature a video appearance by Warren Buffett’s colleague, Charlie Munger. It will also hear from Caledonia Investments chairman Mark Nelson and Regal Funds chief investment officer Phil King.

The local conferences, which began in 2016 have raised more than $30m for medical research.

The Sohn Hearts & Minds Conference will be held on December 3.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 15, 2021. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
Ellerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy Photography
November 15, 2024

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15, 2024

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15, 2024

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
Markets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFP
November 15, 2024

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15, 2024

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15, 2024

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.